Nexstim
Terms of the rights issue announcedNexstim
Securing the commercial future of NBT in depressionNexstim
Achieving commendable outcomes in depressionNexstim
Navigating the opportunity in depressionNexstim
E-FIT stroke trial results disappointNexstim
The defining inflection point expected within three weeksNexstim
First NBT system delivered in US for Major Depression indicationNexstim
Entering the next stimulating phase